MyFinsight
Home
Blog
About
Marketable securities
$80,569K
(-53.06%↓ Y/Y)
Cash and cash
equivalents
$35,769K
(-18.60%↓ Y/Y)
Prepaid expenses and
other current assets
$5,736K
(-41.30%↓ Y/Y)
Accounts receivable
$2,932K
(75.15%↑ Y/Y)
Related party
collaboration receivable
$222K
(-73.91%↓ Y/Y)
Total current assets
$125,228K
(-45.05%↓ Y/Y)
Marketable securities,
non-current
$32,476K
(-30.08%↓ Y/Y)
Operating lease,
right-of-use assets
$25,905K
(-16.36%↓ Y/Y)
Property and equipment,
net
$11,194K
(-19.58%↓ Y/Y)
Restricted cash
$2,736K
(-4.80%↓ Y/Y)
Other non-current
assets
$214K
Total assets
$197,753K
(-38.61%↓ Y/Y)
Total liabilities and
stockholders' equity
$197,753K
(-38.61%↓ Y/Y)
Total stockholders'
equity
$154,377K
(-36.72%↓ Y/Y)
Total liabilities
$43,376K
(-44.50%↓ Y/Y)
Accumulated deficit
-$498,315K
(-27.58%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$421K
(-90.50%↓ Y/Y)
Additional paid-in capital
$653,052K
(2.89%↑ Y/Y)
Operating lease
liabilities, net of current...
$25,691K
(-21.11%↓ Y/Y)
Total current
liabilities
$16,685K
(-60.26%↓ Y/Y)
Other non-current
liabilities
$1,000K
(0.00%↑ Y/Y)
Common stock, 0.001 par
value 240,000,000 and...
$61K
(8.93%↑ Y/Y)
Accrued expenses
$7,951K
(-33.88%↓ Y/Y)
Operating lease
liabilities
$6,876K
(-9.96%↓ Y/Y)
Accounts payable
$1,614K
(-10.53%↓ Y/Y)
Deferred revenue
$244K
(-98.81%↓ Y/Y)
Back
Back
Balance Sheet
Voyager Therapeutics, Inc. (VYGR)
Voyager Therapeutics, Inc. (VYGR)
source: myfinsight.com